ProAssurance Co. (NYSE:PRA – Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 481,100 shares, a decrease of 15.7% from the November 30th total of 571,000 shares. Approximately 1.0% of the shares of the stock are short sold. Based on an average trading volume of 257,700 shares, the short-interest ratio is presently 1.9 days.
Analyst Upgrades and Downgrades
Several research firms have weighed in on PRA. StockNews.com raised ProAssurance from a “hold” rating to a “buy” rating in a report on Thursday. Truist Financial raised their target price on shares of ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, November 12th. Finally, Piper Sandler downgraded shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price target on the stock. in a report on Monday, November 11th.
Check Out Our Latest Stock Report on PRA
Institutional Inflows and Outflows
ProAssurance Price Performance
Shares of NYSE PRA traded up $0.02 during trading on Monday, reaching $15.68. The company had a trading volume of 16,991 shares, compared to its average volume of 277,963. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. ProAssurance has a twelve month low of $10.76 and a twelve month high of $17.79. The stock has a 50-day moving average price of $16.19 and a two-hundred day moving average price of $14.17. The stock has a market capitalization of $802.13 million, a PE ratio of 18.89 and a beta of 0.28.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Read More
- Five stocks we like better than ProAssurance
- What is the Dow Jones Industrial Average (DJIA)?
- Micron: Why Now Is the Time to Be Brave
- What is the S&P/TSX Index?
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
- Transportation Stocks Investing
- 3 Reasons Costco Stock Will Have More Room to Run in 2025
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.